Abstract：
With the in-depth understanding of osteonecrosis of femoral head (ONFH), and more and more patients seeking medical treatment in the early stage of the disease, surgical treatment of femoral head necrosis alone is no longer sufficient for the current treatment of patients\' demand, how to rationally and effectively apply drugs to strengthen the early prevention and treatment of femoral head necrosis and delay the progression of disease is becoming more and more important. This article combines the latest expert consensus and evidence-based medical evidence on the principles of ONFH diagnosis and treatment in Chinese and Western medicine at home and abroad, combined with domestic actual clinical application experience, and is organized by experts from Association Related to Circulation Osseous Chinese Microcirculation Society (CSM-ARCO) to write this consensus, focusing on the types of ONFH drugs, the characteristics, safety, rationality and basic principles of drug use provide reference opinions for the safe, reasonable, standardized and effective drug use of medical institutions at all levels. This consensus is only an expert guideline based on literature and clinical experience, not as a requirement for mandatory implementation, let alone as a legal basis. The clinical practice could be tailored to the actual local conditions to develop appropriate prevention and treatment measures for patients.
摘要：
随着对股骨头坏死(ONFH)认识的深入,越来越多的患者在疾病早期寻求治疗，单纯手术治疗股骨头坏死已不足以满足目前患者的治疗需求,如何合理有效地应用药物加强股骨头坏死的早期预防和治疗,延缓病情进展,显得越来越重要。本文结合国内外最新专家共识和循证医学证据,对ONFH的中西医诊疗原则,结合国内实际临床应用经验,并由中国骨体微循环学会相关协会(CSM-ARCO)的专家组织撰写本共识，专注于ONFH药物的类型，的特点,安全,用药的合理性和基本原则,为安全用药提供参考意见,合理,规范、有效的各级医疗机构用药。这种共识只是基于文献和临床经验的专家指南，不是强制性实施的要求，更不用说作为法律依据了。临床实践可根据当地实际情况制定相应的预防和治疗措施。
